Wednesday, May 05, 2021 9:59:52 AM
https://insiderfinancial.com/penny-stock-to-watch-htzgq-icbu-rvvtf-shmn/181388/
If Bucillamine succeeds as an efficient oral treatment for COVID and gets approved by the FDA, the stock price of RVVTF is expected to surge as the pandemic figures continue to increase. While the vaccination campaigns will likely go on for the years to come, there is a huge demand for COVID treatment as well, and there aren’t many treatment options so far.
Besides Bucillamine, Revive is advancing the development of Psilocybin-based treatments for mental illness and neurological disorders after the acquisition of Psilocin Pharma Corp.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM